Rituxan Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-guided Dose Reduction in Patients With Rheumatoid Arthritis
Condition:   Rheumatoid Arthritis Intervention:   Drug: Rituximab Sponsors:   Universitaire Ziekenhuizen KU Leuven;   Fonds voor Wetenschappelijk Reumaonderzoek (FWRO) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

ZR2 Sequential Immunochemotherapy for Newly Treated MCL
Condition:   Rituximab, Lenalidomide, Zebutinib ，Mantle Cell Lymphoma Intervention:   Drug: ZR2 RDHAP Sponsor:   Zhejiang Cancer Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials